查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1835600

减重手术设备市场（按手术类型、设备类型、技术和最终用户划分）—2025-2032 年全球预测

Obesity Surgery Devices Market by Procedure Type, Device Type, Technology, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年减重手术设备市场将成长至 82.2 亿美元，复合年增长率为 8.15%。

主要市场统计数据
基准年2024年 43.9亿美元
预计2025年 47.5亿美元
预测年份：2032年 82.2亿美元
复合年增长率（%） 8.15%

全面介绍减肥手术设备的现况与策略重要性

减重手术器材处于临床需求、加速技术应用和不断发展的医疗服务模式的交会点。过去十年，临床医生和器械开发者一直在努力应对不断变化的优先事项：提高手术安全性和疗效、缩短手术时间以及扩大门诊就诊管道。这些驱动因素，加上患者对微创治疗方案的需求以及支付方对长期成本控制的日益关注，使得器械策略必须具备明确的临床差异化和实用的价值提案。

随着减重护理整合多学科术前优化和长期代谢随访，临床路径日趋成熟。因此，设备设计的重点正从简单的手术支援转向端到端的护理支持，强调人体工学、与不断发展的手术平台的兼容性以及与医院和门诊工作流程的无缝整合。同时，监管审查和对真实世界证据日益增长的期望，促使开发商投资更强大的临床项目和长期结果追踪。

综上所述，这种环境将有利于那些能够兼顾临床有效性和营运效率，同时管理供应链弹性和报销复杂性的公司。相关人员在规划产品蓝图和商业化策略时，需要在证据产生和平台互通性的长期投资与短期应用之间取得平衡。

变革性变革重新定义减重手术设备竞争优势与临床路径

过去几年，各种变革性变化正在重新定义医疗器材的竞争优势。机器人技术和先进的视觉化系统已从辅助工具转变为核心平台，改变了手术的规划和执行方式。增强的内视镜技术，包括更强大的吻合器和缝合功能，正在实现更微创的干预，并为此前选择有限的患者开闢新的治疗途径。除了这些技术变革之外，植入材料和输液港系统也得到了改进，旨在降低併发症发生率并简化再次手术流程。

同时，医疗保健服务模式也在不断演变，住院时间缩短、手术全期管道优化以及支付方降低成本的奖励，使得手术尽可能转移到门诊手术中心和专科诊所。这种转变需要设备易于小型团队使用、能够适应有限的基础设施，并由高效的供应链和灭菌工作流程提供支援。以金额为准的采购模式越来越重视可证明的疗效，迫使研发人员将临床证据策略与经济终点结合。

创新不再只是关乎设备本身，也关乎其周边的生态系统。数位健康整合、远端监控和数据主导的患者选择正成为硬体进步的重要补充。产业相关人员的策略重点是将这些要素整合成一个紧密结合的解决方案，以改善患者治疗效果、降低总治疗成本，并支援在不同医疗环境中进行可扩展的部署。

2025年美国关税变化对供应链商业策略与临床实施动态的累积影响

2025年，美国实施新的或更高的关税，将对整个减肥设备生态系统产生单独且累积的影响。先前从海外供应商采购零件和成品的製造商面临到岸成本上升的局面，这促使他们迅速重新审视筹资策略。为此，一些公司加快了供应商多元化，建立了区域配送中心，并加强了谈判，以缓解利润压力。这些营运应对措施将影响前置作业时间、库存策略和资本配置决策。

为了应对关税带来的成本压力，医院和门诊手术中心的采购团队调整了采购合同，优先考虑那些能够显着节省营运成本并降低併发症发生率的设备。结果，拥有强大价值剂量分摊和总护理成本证据的设备供应商在系统级采购组织中占据了优先地位，而缺乏差异化临床或经济价值的产品则面临采用阻力。随着时间的推移，由于客户优先维护核心功能并推迟购买非必需产品，设备的生命週期和升级计划也发生了变化。

关税也改变了竞争格局，削弱了低成本国际参与企业的相对优势，并为本地製造业投资创造了奖励。随着企业处理海关分类和文件，监管和合规工作量也随之增加。展望未来，企业将继续投资于本地製造能力和与分销合作伙伴共用关税风险的合约结构，而付款方和供应商将优先考虑采购弹性和供应商的弹性。

关键细分洞察揭示了特定设备和程序的商业机会和差异化策略

将机会细分，可以发现临床需求、采购週期和创新重点方面有显着差异。考虑到胃束带调整术、胃绕道手术和袖状切除术等手术类型，对器械的要求也有所不同。胃束带调整术注重植入的寿命和输液港系统的可靠性；胃旁路手术更注重复杂的吻合和吻合口的完整性；袖状切除术需要耐用的吻合平台以及在不同组织条件下吻合器性能的稳定性。这些细分领域影响产品开发的重点和开发后监测策略。

按器械类型细分后发现，切割和缝合器械、内视镜器械、植入和视觉化系统各自拥有不同的临床和商业性策略。在内视镜器械领域，缝合和缝合器械的子领域呈现不同的应用轨迹，由临床医生技能和手术流程驱动。同样，诸如带状系统和端口系统等植入类别需要持续专注于生物相容性、感染预防和提取物流，从而塑造售后服务和保固制度。

腹腔镜、开放性手术和机器人手术方法的技术细分导致不同的资本和培训要求。机器人解决方案，无论是多臂还是单端口配置，通常都需要更高的前期投资和更长的采用曲线，但可以实现更高的精度和新颖的程序方法。最后，门诊手术中心、医院和专科诊所（医院进一步分为私立和公立）的最终用户细分导致不同的采购週期、采购权限和营运限制。门诊中心通常需要高效的轮调和精简的消毒，私立医院优先考虑支援广泛服务线的优质平台，而公立医院通常优先考虑成本效益和标准化。这种分层细分对于使临床证据、定价和打入市场策略与每个相关人员的需求保持一致至关重要。

区域洞察突显了全球市场中不同的采用管道和策略重点

区域动态持续影响减重手术设备的投资重点和采用模式。在美洲，成熟的医院体系和私人支付环境支援先进视觉化和机器人平台的快速普及。同时，门诊手术中心透过高效的排班和缩短患者住院时间，正在扩大其服务人群。设备供应商与大型综合医疗服务网络之间的伙伴关係，对于试点新技术和收集真实世界证据日益重要。

欧洲、中东和非洲的地区差异性显而易见。西方体系通常强调严格的卫生技术评估和成本效益，要求提供强有力的临床和经济证明，以便获得报销和在系统层面推广应用。同时，非洲部分地区仍受到基础设施和劳动力的限制，因此更注重在资源有限的环境下能够有效运作的耐用、低维护的解决方案。

亚太市场的特点是手术量快速成长、法规差异化以及对机器人和微创平台的大量投资。该地区一些国家正在扩大三级医疗中心的手术能力，并开展培训计画以支持复杂的手术。韧性供应链、本地化定制的监管策略以及兼顾文化差异的病人参与，对于在该地区成功且持续地推出产品至关重要。

主要企业强调策略定位洞察技术重点与协作的重要性

产业参与者正朝着不同的策略方向发展，现有的医疗设备製造商专注于整合平台开发和产生监管级证据，而创新挑战者则专注于利基技术优势，例如新型缝合机制、缝合方法、单端口机器人解决方案等。竞争差异化越来越依赖将硬体与服务、临床培训和数据分析相结合的能力，从而展示更好的结果和简化的手术全期流程。

设备开发人员、机器人平台提供者和临床卓越中心之间的合作正在加速临床应用，从而解决技术和培训方面的障碍。授权、联合开发伙伴关係和服务协议正在加速专用设备的开发，同时共用开发风险。此外，投资于全面的上市后监测和真实世界证据收集的公司更有能力满足付款人的需求，并获得优先供应商协议。

那些在可视化、吻合和内视镜系统中註重模组化和互通性的製造商，正获得寻求长期资本效率的医院系统的支持，而那些在监管敏捷性和本地化打入市场策略表现优异的公司，则正在快速增长的地区抓住机会。对于所有参与者而言，将产品蓝图与临床医生工作流程和采购实际情况一致，仍然是预测其能否持久应用的最可靠指标。

为行业领导者提供可行的建议，将见解转化为商业性和临床效益

首先，优先投资于将设备性能与以患者为中心和事件层面的治疗结果联繫起来的临床证据。其次，确保设备易于使用、快速更换，并尽量减少对基础设施的要求，以吸引门诊手术中心和专科诊所。第三，透过多元化供应商、建立区域库存缓衝以及考虑本地化製造和组装以降低关税和物流风险，增强供应链的韧性。

第四，我们追求互通性和模组化，实现与主流视觉化和机器人平台的集成，从而降低客户转换成本并提升交叉销售潜力。第五，我们根据私人医院、公立医院和门诊病人的需求，客製化培训计划、保固模式和服务合同，为不同的最终用户制定差异化的价值提案。第六，我们积极与付款方和卫生技术评估机构合作，协调证据产生和报销标准，并探索基于结果共担风险的创新合约模式。

最后，与临床领先企业和卓越中心建立伙伴关係，以加速采用、完善程序通讯协定并产生高品质的真实世界数据，这将共同创造广泛的市场地位，平衡短期商业性吸引力和长期永续性。

调查方法详述了用于开发可操作和可复製见解的多模态方法

本分析整合了多模态研究途径，结合了同行评审临床文献的系统综述、公共监管提交和设备核准的分析以及临床实验室登记的综合分析，以绘製证据库的成熟度图。主要研究包括对外科医生、采购负责人、门诊手术中心管理人员和临床教育工作者的结构化访谈，以了解现实世界中采用该技术的驱动因素和工作流程的限制。此外，还对来自设备登记、付款人政策声明和外科协会指南的二次资料流进行了三角测量，以检验趋势并识别证据缺口。

增强型市场情报透过产品级基准测试和比较技术评估进行增强，这些评估考察了设备设计、与手术平台的兼容性以及服务模式。供应炼和关税影响分析是基于物流数据和供应商揭露，并运用情境规划来确定製造商和医疗保健提供者可用的营运槓桿。在整个研究过程中，我们应用了资料品管和交叉检验技术，以减少偏差并确保可重复性。我们承认，在公开资料稀缺或地区差异限制了普遍性的情况下，本研究有其限制。

结论：对整个生态系统相关人员的策略影响和未来方向的总结

减重手术器械产业正处于技术创新、不断发展的护理环境和不断变化的采购动态交汇的关键时刻。在这种环境下取得成功需要一种整体方法，将差异化器械性能与严谨的临床证据、灵活的商业模式和富有弹性的供应链相结合。随着门诊规模的扩大以及机器人和内视镜技术的成熟，那些优先考虑互通性、临床医生培训和疗效等提案主张的公司将拥有最清晰的持续应用路径。

不断变化的关税和区域差异凸显了灵活的筹资策略和区域市场规划的重要性。相关人员应在短期营运需求与长期证据和平台开发投资之间取得平衡。透过使产品设计与最终用户工作流程和付款人期望相一致，并建立能够产生高品质真实世界数据的临床医生伙伴关係关係，行业参与者可以将新兴趋势转化为可持续的竞争优势并改善患者治疗效果。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 机器人辅助腹腔镜器械在复杂性袖状切除术的应用日益增多
  • 开发生物可吸收胃植入，旨在最大程度降低慢性异物反应的风险
  • 扩大内视镜经口袖状胃成形术装置，实现门诊病人减重减重
  • 整合感测器的胃内球囊，用于即时监测胃内压力和容量
  • 结合机械限制和肽激素输送功能的双功能胃内球囊的出现
  • 3D 列印患者专用胃束带和支架可优化贴合度并降低併发症率
  • 使用远端医疗连接的可穿戴监测系统来追踪术后体重减轻和营养依从性

第六章 2025年美国关税的累积影响

第七章 人工智慧的累积影响，2025年

8. 减重手术器械市场（依手术类型）

  • 可调式胃束带手术
  • 胃绕道手术
  • 袖状切除术

9. 减重手术设备市场（依设备类型）

  • 切割和装订设备
  • 内视镜设备
    • 装订设备
    • 缝合器
  • 植入
    • 乐队系统
    • 港口系统
  • 视觉化系统

第 10 章减肥手术设备市场（按技术）

  • 腹腔镜
  • 打开
  • 机器人
    • 多臂
    • 单埠

第 11 章减重手术设备市场（依最终用户划分）

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所

第十二章 减重手术器械市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 减肥手术器械市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国减肥手术器械市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Johnson & Johnson
    • Medtronic plc
    • Becton, Dickinson and Company
    • Intuitive Surgical, Inc.
    • Stryker Corporation
    • Olympus Corporation
    • Smith & Nephew plc
    • CONMED Corporation
    • Boston Scientific Corporation
    • Teleflex Incorporated
Product Code: MRR-036C5CF3A89F

The Obesity Surgery Devices Market is projected to grow by USD 8.22 billion at a CAGR of 8.15% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.39 billion
Estimated Year [2025] USD 4.75 billion
Forecast Year [2032] USD 8.22 billion
CAGR (%) 8.15%

A Comprehensive Introduction Framing the Current State and Strategic Imperatives for Obesity Surgery Devices

The obesity surgery devices landscape sits at the intersection of clinical necessity, accelerating technology adoption, and evolving care delivery models. Over the past decade clinicians and device developers have navigated a shifting set of priorities: improving operative safety and outcomes, reducing procedure times, and expanding access to ambulatory settings. These drivers coalesce with patient demand for less invasive options and payers' increasing focus on long-term cost containment, requiring device strategies that offer clear clinical differentiation alongside pragmatic value propositions.

Clinical pathways are maturing as bariatric care integrates multidisciplinary preoperative optimization and long-term metabolic follow-up. Consequently, device design priorities have transitioned from mere procedural enablement to end-to-end care support, emphasizing ergonomics, compatibility with evolving surgical platforms, and seamless incorporation into hospital and ambulatory workflows. Concurrently, regulatory scrutiny and heightened expectations for real-world evidence are prompting developers to invest in more robust clinical programs and longitudinal outcome tracking.

Taken together, this environment rewards companies that can demonstrate both clinical efficacy and operational efficiency, while also managing supply chain resilience and reimbursement complexity. As stakeholders plan product roadmaps and commercialization strategies, they must balance near-term adoption levers against longer-term investments in evidence generation and platform interoperability.

Transformative Shifts Redefining Competitive Advantage and Clinical Pathways in Obesity Surgery Devices

The past several years have produced transformative shifts that are redefining competitive advantage across the device landscape. Robotics and advanced visualization systems have moved from adjunct tools to core platforms that change how procedures are planned and executed. Enhanced endoscopic approaches, including expanded stapling and suturing capabilities, are enabling less invasive interventions and opening new pathways for patients who previously faced limited options. These technology shifts are compounded by improvements in implant materials and port systems that aim to reduce complication rates and streamline revision procedures.

Simultaneously, care delivery models are evolving as surgeries migrate into ambulatory surgical centers and specialty clinics where feasible, driven by shorter stays, optimized perioperative pathways, and payer incentives for lower-cost settings. This shift requires devices that are facile for smaller teams, compatible with limited infrastructure, and supported by efficient supply chain and sterilization workflows. Payer and policy landscapes are also influencing device adoption; value-based procurement models increasingly prioritize demonstrable outcomes, driving developers to align clinical evidence strategies with economic endpoints.

Innovation is no longer exclusively about the device itself but also about the ecosystem around it. Digital health integration, remote monitoring, and data-driven patient selection are becoming essential complements to hardware advances. For industry players, the strategic priority is to integrate these elements into cohesive solutions that improve patient outcomes, reduce total episode costs, and support scalable adoption across diverse care settings.

Cumulative Effects of United States Tariff Changes in 2025 on Supply Chains Commercial Strategy and Clinical Adoption Dynamics

The introduction of new or higher tariffs in the United States during 2025 has introduced discrete and cumulative effects across the obesity surgery devices ecosystem. Manufacturers that historically sourced components or finished goods from international suppliers faced increased landed costs, prompting rapid reassessments of sourcing strategies. In response, several firms accelerated supplier diversification, established regional distribution centers, and intensified negotiations to mitigate margin erosion. These operational responses have repercussions for lead times, inventory strategies, and capital allocation decisions.

Procurement teams within hospitals and ambulatory surgical centers reacted to tariff-driven cost pressures by reassessing purchasing agreements and prioritizing devices that deliver clear operational savings or lower complication rates. As a result, device suppliers with robust value dossiers and total-cost-of-care evidence secured preferred positions with system-level purchasing organizations, while products lacking differentiated clinical or economic value encountered adoption headwinds. Over time, device lifecycles and upgrade cadences shifted as customers deferred nonessential acquisitions in favor of maintaining core capabilities.

Tariffs also altered the competitive landscape by lowering the relative advantage of some low-cost foreign entrants and by creating incentives for regional manufacturing investments. Regulatory and compliance workloads increased as firms navigated customs classifications and documentation. Looking forward, companies are likely to continue investing in localized manufacturing capability and in contractual structures that share tariff risk with distribution partners, while payers and providers emphasize procurement flexibility and supplier resilience.

Key Segmentation Insights Illuminating Device and Procedure-Specific Opportunities and Differentiation Strategies

Segmenting the opportunity set reveals meaningful differences in clinical needs, procurement cycles, and innovation priorities. When considering procedure type across adjustable gastric banding, gastric bypass, and sleeve gastrectomy, device requirements diverge: adjustable gastric banding emphasizes implant longevity and port system reliability, gastric bypass places higher emphasis on complex stapling and anastomosis integrity, and sleeve gastrectomy demands durable stapling platforms and consistent stapler performance under variable tissue conditions. These distinctions influence product development priorities and post-market surveillance strategies.

Exploring device type segmentation illuminates how cutting and stapling devices, endoscopic devices, implants, and visualization systems each command distinct clinical and commercial playbooks. Within endoscopic devices, the subdomains of stapling devices and suturing devices present separate adoption trajectories driven by clinician skillsets and procedural workflows. Similarly, implant categories such as band systems and port systems require sustained attention to biocompatibility, infection prevention, and explant logistics, shaping after-market services and warranty structures.

Technology segmentation across laparoscopic, open, and robotic approaches highlights divergent capital and training requirements. Robotic solutions-whether multi-arm or single-port configurations-often involve higher upfront investment and longer onboarding curves but can enable greater precision and novel procedural approaches. Finally, end-user segmentation spanning ambulatory surgical centers, hospitals, and specialty clinics, with hospitals further differentiated into private and public institutions, dictates differing procurement cycles, purchasing authority, and operational constraints. Ambulatory settings demand efficient turnover and streamlined sterilization, private hospitals may prioritize premium platforms that support broader service lines, and public hospitals often emphasize cost-effectiveness and standardization. These layered segmentations are essential for tailoring clinical evidence, pricing, and go-to-market strategies that align with the needs of each stakeholder group.

Regional Insights Highlighting Varied Adoption Pathways and Strategic Priorities across Global Markets

Regional dynamics continue to shape investment priorities and adoption patterns across the obesity surgery devices landscape. In the Americas, established hospital systems and a mature private-pay environment support rapid uptake of advanced visualization and robotic platforms, while ambulatory surgical centers expand the addressable population by enabling efficient scheduling and shorter patient stays. Partnerships between device suppliers and large integrated delivery networks are increasingly important for piloting new technologies and collecting real-world evidence.

In Europe, Middle East & Africa, regional heterogeneity is pronounced. Western European systems often emphasize rigorous health technology assessment and cost-effectiveness, requiring robust clinical and economic dossiers for reimbursement and system-level adoption. Middle Eastern markets present opportunities for rapid capital investment and center-of-excellence development, whereas parts of Africa remain constrained by infrastructure and workforce limitations, creating a focus on durable, low-maintenance solutions that can function in resource-limited settings.

Asia-Pacific markets are characterized by a mix of rapid surgical volume growth, varying regulatory pathways, and significant investment in robotic and minimally invasive platforms. Several countries in the region are building surgical capacity in tertiary centers and expanding training programs that support complex procedures. Across all regions, supply chain resilience, localized regulatory strategies, and culturally informed patient engagement are critical to successful product introductions and sustained adoption.

Key Companies Insights Emphasizing Strategic Positioning Technology Focus and Collaboration Imperatives

Industry participants vary widely in strategic orientation, with established medical device leaders focusing on integrated platform development and regulatory-grade evidence generation, while innovative challengers concentrate on niche technological advantages such as novel stapling mechanics, suturing modalities, or single-port robotic solutions. Competitive differentiation increasingly depends on the ability to bundle hardware with services, clinical training, and data analytics that demonstrate improved outcomes and streamlined perioperative workflows.

Collaborations between device developers, robotic platform providers, and clinical centers of excellence are accelerating clinical adoption by addressing both technical and training barriers. Licensing arrangements, co-development partnerships, and service contracts enable faster market entry for specialized devices while sharing development risk. Additionally, companies investing in comprehensive post-market surveillance and real-world evidence collection are better positioned to respond to payer demands and to secure preferred provider agreements.

Manufacturers that prioritize modularity and interoperability across visualization, stapling, and endoscopic systems are gaining traction with hospital systems seeking long-term capital efficiency. Meanwhile, firms that excel at nimble regulatory navigation and localized market entry strategies are capturing opportunities in rapidly growing regions. For all participants, aligning product roadmaps with clinician workflows and procurement realities remains the most consistent predictor of durable adoption.

Actionable Recommendations for Industry Leaders to Translate Insight into Commercial and Clinical Advantage

First, prioritize investments in clinical evidence that tie device performance to relevant patient-centric and episode-level outcomes; robust longitudinal data will be critical for negotiations with payers and large provider systems. Second, design devices and commercial models with ambulatory adoption in mind, ensuring ease of use, rapid turnover, and minimal ancillary infrastructure requirements to appeal to ambulatory surgical centers and specialty clinics. Third, fortify supply chain resilience by diversifying suppliers, establishing regional inventory buffers, and exploring localized manufacturing or assembly to mitigate tariff and logistics risk.

Fourth, pursue interoperability and modularity, enabling devices to integrate with prevailing visualization and robotic platforms, which lowers switching costs for customers and enhances cross-selling potential. Fifth, develop differentiated value propositions for distinct end users by tailoring training programs, warranty models, and service contracts to the needs of private hospitals, public hospitals, and outpatient settings. Sixth, engage proactively with payers and health technology assessment bodies to align evidence generation with reimbursement criteria and to explore innovative contracting approaches that share risk based on outcomes.

Finally, foster partnerships with clinical champions and centers of excellence to accelerate adoption, refine procedural protocols, and generate high-quality real-world data. These actions combined will create a defensible market position that balances near-term commercial traction with long-term sustainability.

Research Methodology Detailing the Multimodal Approach Used to Develop Actionable and Reproducible Insights

This analysis integrates a multimodal research approach combining systematic review of peer-reviewed clinical literature, analysis of public regulatory filings and device approvals, and synthesis of clinical trial registries to map evidence maturity. Primary qualitative research included structured interviews with surgeons, procurement leaders, ambulatory surgical center administrators, and clinical educators to capture real-world adoption drivers and workflow constraints. In addition, secondary data streams from device registries, payer policy statements, and surgical society guidelines were triangulated to validate trends and identify gaps in evidence.

Market-facing intelligence was augmented by product-level benchmarking and comparative technology assessments that examined device design, compatibility with surgical platforms, and service models. Supply chain and tariff impact analyses were informed by logistics data and supplier disclosures, with scenario planning used to surface operational levers available to manufacturers and providers. Throughout the research process, data quality controls and cross-validation techniques were applied to limit bias and ensure reproducibility. Limitations are acknowledged where public data are sparse or where regional variability constrains generalizability; in such cases, findings are framed as directional rather than definitive.

Conclusion Summarizing Strategic Implications and the Path Forward for Stakeholders Across the Ecosystem

The obesity surgery devices sector stands at a pivotal moment where technological innovation, evolving care settings, and shifting procurement dynamics intersect. Success in this environment requires a holistic approach that couples differentiated device performance with rigorous clinical evidence, adaptable commercial models, and resilient supply chains. As ambulatory settings expand and robotic and endoscopic capabilities mature, companies that prioritize interoperability, clinician training, and outcome-focused value propositions will capture the clearest pathways to sustained adoption.

Tariff shifts and regional heterogeneity underscore the importance of flexible sourcing strategies and localized market plans. Stakeholders should balance near-term operational needs with investments in long-term evidence and platform development. By aligning product design with end-user workflows and payer expectations, and by fostering clinician partnerships that generate high-quality real-world data, industry players can convert emerging trends into durable competitive advantage and improved patient care outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increased adoption of robotic-assisted laparoscopic instruments for complex sleeve gastrectomy procedures
  • 5.2. Development of bioresorbable gastric implants designed to minimize chronic foreign body reaction risks
  • 5.3. Expansion of endoscopic transoral sleeve gastroplasty devices enabling outpatient weight loss interventions
  • 5.4. Integration of sensor-enabled intragastric balloons for real-time monitoring of gastric pressure and volume
  • 5.5. Emergence of dual-function intragastric balloons combining mechanical restriction with peptide hormone delivery capabilities
  • 5.6. Adoption of 3D printing for patient-specific gastric bands and stents to optimize fit and reduce complication rates
  • 5.7. Use of telehealth-connected wearable monitoring systems to track postoperative weight loss and nutritional compliance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Obesity Surgery Devices Market, by Procedure Type

  • 8.1. Adjustable Gastric Banding
  • 8.2. Gastric Bypass
  • 8.3. Sleeve Gastrectomy

9. Obesity Surgery Devices Market, by Device Type

  • 9.1. Cutting And Stapling Devices
  • 9.2. Endoscopic Devices
    • 9.2.1. Stapling Devices
    • 9.2.2. Suturing Devices
  • 9.3. Implants
    • 9.3.1. Band Systems
    • 9.3.2. Port Systems
  • 9.4. Visualization Systems

10. Obesity Surgery Devices Market, by Technology

  • 10.1. Laparoscopic
  • 10.2. Open
  • 10.3. Robotic
    • 10.3.1. Multi Arm
    • 10.3.2. Single Port

11. Obesity Surgery Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialty Clinics

12. Obesity Surgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Obesity Surgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Obesity Surgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. Becton, Dickinson and Company
    • 15.3.4. Intuitive Surgical, Inc.
    • 15.3.5. Stryker Corporation
    • 15.3.6. Olympus Corporation
    • 15.3.7. Smith & Nephew plc
    • 15.3.8. CONMED Corporation
    • 15.3.9. Boston Scientific Corporation
    • 15.3.10. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. OBESITY SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. OBESITY SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OBESITY SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GASTRIC BYPASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SLEEVE GASTRECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY CUTTING AND STAPLING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY BAND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PORT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY OPEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY MULTI ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SINGLE PORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL OBESITY SURGERY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY ROBOTIC, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN OBESITY SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 313. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 320. GCC OBESITY SURGERY DEVICES MARKET SIZE, BY EN